Inventor · disambiguated record
Bertrand Le Bourdonnec
Also filed as: LE BOURDONNEC BERTRAND
34 granted patents·36 pending applications·191 citations·filing 2002–2025
97Inventor score
Files withADOLOR CORP28JANSSEN PHARMACEUTICA NV12DOLLE ROLAND E8DECIPHERA PHARMACEUTICALS LLC7KINETA INC6
Top patents by PatentIndex Score
70 records- 0194US7087749B2Substituted piperidine compounds and methods of their useADOLOR CORP·Filed 2004·Granted Aug 8, 2006·36 cites·34 claims
- 0292US12275723B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Apr 15, 2025·1 cites·16 claims
- 0391US10973810B2Methods for the treatment of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2018·Granted Apr 13, 2021·7 cites·10 claims
- 0491US7884102B2Substituted piperidine compounds and methods of their useADOLOR CORP·Filed 2008·Granted Feb 8, 2011·15 cites·55 claims
- 0591US6992090B2Substituted piperidine compounds and methods of their useADOLOR CORP·Filed 2003·Granted Jan 31, 2006·37 cites·27 claims
- 0689US7767814B2Substituted piperidine compounds and methods of their useADOLOR CORP·Filed 2006·Granted Aug 3, 2010·5 cites·62 claims
- 0789US7338962B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2004·Granted Mar 4, 2008·19 cites·5 claims
- 0888US6794510B2Processes for the preparation of peripheral opioid antagonist compounds and intermediates theretoADOLOR CORP·Filed 2002·Granted Sep 21, 2004·16 cites·14 claims
- 0987US7638527B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2007·Granted Dec 29, 2009·5 cites·26 claims
- 1086US12433880B2Methods for the treatment of neurological disordersJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 7, 2025·1 cites·23 claims
- 1186US11970486B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 30, 2024·3 cites·12 claims
- 1286US7598261B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2006·Granted Oct 6, 2009·7 cites·93 claims
- 1384US8278323B2Opioid antagonistsDOLLE ROLAND E·Filed 2009·Granted Oct 2, 2012·2 cites·32 claims
- 1482US12180221B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 31, 2024·1 cites·20 claims
- 1582US8580788B2Opioid antagonistsDOLLE ROLAND E·Filed 2012·Granted Nov 12, 2013·2 cites·18 claims
- 1682US7538110B2Opioid antagonistsADOLOR CORP·Filed 2006·Granted May 26, 2009·4 cites·90 claims
- 1781US7820827B2Substituted piperidine compounds and methods of their useADOLOR CORP·Filed 2005·Granted Oct 26, 2010·3 cites·18 claims
- 1880US7906646B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2009·Granted Mar 15, 2011·2 cites·4 claims
- 1980US2024300938A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2080US2025034125A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2180US2024400546A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2280US2025034124A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2379US11873298B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 16, 2024·1 cites·8 claims
- 2479US7576207B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2007·Granted Aug 18, 2009·3 cites·62 claims
- 2578US7381721B2Substituted piperidine compoundsADOLOR CORP·Filed 2003·Granted Jun 3, 2008·9 cites·37 claims
- 2678US7091354B2Processes for the preparation of peripheral opioid antagonist compounds and intermediates theretoADOLOR CORP·Filed 2004·Granted Aug 15, 2006·7 cites·11 claims
- 2777US8071611B2Spirocyclic heterocyclic derivatives and methods of their useDOLLE ROLAND E·Filed 2010·Granted Dec 6, 2011·2 cites·16 claims
- 2877US2025304569A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 2976US2025250235A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 3076US2009233959A1Beloxepin and analogs for the treatment of painADOLOR CORP·Filed 2009·Application pending·0 cites
- 3174US8022060B2Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2009·Granted Sep 20, 2011·1 cites·206 claims
- 3271US8895560B2Opioid antagonistsADOLOR CORP·Filed 2014·Granted Nov 25, 2014·0 cites·6 claims
- 3370US12319655B2RAF kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Jun 3, 2025·0 cites·31 claims
- 3467US2013317035A1Novel opioid antagonistsDOLLE ROLAND E·Filed 2013·Application pending·0 cites
- 3566US12098146B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 24, 2024·0 cites·22 claims
- 3666US2024376058A1Gcn2 and perk kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 3763US11241417B2Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·0 cites·8 claims
- 3863US2022110920A1Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3962US7829576B2Beloxepin and analogs for the treatment of painADOLOR CORP·Filed 2010·Granted Nov 9, 2010·0 cites·18 claims
- 4062US2025353851A1Purines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 4161US2025206729A1Dual raf and tubulin inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 4261US2023357179A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 4360US2025288589A1Pyridopyrimidines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 4460US2025145642A1Bicyclic heteroarenes and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 4560US2010196269A1Spirocyclic heterocyclic derivatives and methods of their useADOLOR CORP·Filed 2009·Application pending·0 cites
- 4660US2024150368A1Ulk inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 4758US11912668B2GCN2 and perk kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Feb 27, 2024·0 cites·15 claims
- 4858US6992193B2Sulfonylamino phenylacetamide derivatives and methods of their useADOLOR CORP·Filed 2003·Granted Jan 31, 2006·2 cites·23 claims
- 4958US2012165356A1Spirocyclic heterocyclic derivatives and methods of their useDOLLE ROLAND E·Filed 2011·Application pending·0 cites
- 5058US2008275131A1Compositions of (-)-e-10-oh-nt and methods for their synthesis and useADOLOR CORP·Filed 2008·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →